• Citer

Comparison of the efficacy and safety of amikacin once or twice-a-day in the treatment of severe gram-negative infections in the elderly.

par Vanhaeverbeek, Michel ;Siska, G;Douchamps, J;Herchuelz, André
Référence International journal of clinical pharmacology, therapy, and toxicology, 31, 3, page (153-156)
Publication Publié, 1993-03

Article révisé par les pairs

• Détails
• Contenu

Titre:	Comparison of the efficacy and safety of amikacin once or twice-a-day in the treatment of severe gram-negative infections in the elderly.
Auteur:	Vanhaeverbeek, Michel; Siska, G; Douchamps, J; Herchuelz, André
Informations sur la publication:	International journal of clinical pharmacology, therapy, and toxicology, 31, 3, page (153-156)
Statut de publication:	Publié, 1993-03
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Aged
	Amikacin -- administration & dosage
	Amikacin -- adverse effects
	Amikacin -- therapeutic use
	Drug Administration Schedule
	Female
	Gram-Negative Bacterial Infections -- drug therapy
	Humans
	Male
	Middle Aged
Note générale:	Clinical Trial
	Comparative Study
	Journal Article
	Randomized Controlled Trial
Langue:	Anglais
Identificateurs:	urn:issn:0174-4879
	info:pmid/8468114